Navigation Links
Skinvisible Appoints New Board Member
Date:2/1/2008

- Brian Piwek to Assist in Generating New Retail Licensing Opportunities

LAS VEGAS, Feb. 1 /PRNewswire-FirstCall/ -- Skinvisible, Inc. (OTC Bulletin Board: SKVI) (http://www.skinvisible.com), a pharmaceutical company focused on the discovery and development of patented dermatology products with their proprietary polymer delivery system Invisicare(R), today announced that Mr. Brian Piwek has been selected as a new member of the Company's Board of Directors replacing Mr. Jost Steinbruchel, who has resigned as a Board Member. Mr. Steinbruchel has been a Board Member since the company's inception in 1998 and the board and company officers wish to thank him for his valuable contribution during this time.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030416/LAW068LOGO)

(Logo: http://www.newscom.com/cgi-bin/prnh/20040503/INVISICARELOGO)

"We are delighted to have Mr. Brian Piwek join our Board of Directors, as he brings a great deal of experience and additional perspective that will be an asset to Skinvisible as we continue to implement our current initiatives," said Mr. Terry Howlett, President / CEO of Skinvisible. "We are entering an exciting phase at Skinvisible where we begin the commercialization of our dermatology products with international licensees. Brian's business development and retail expertise will be invaluable as Skinvisible continues to pursue its growth goals."

Brian Piwek's experience and expertise is in the international retail industry. He was president of Overwaitea Foods supermarket from 1991 until 1997. In 1997 Brian accepted the position as Co-CEO with A&P Canada (The Great Atlantic & Pacific Tea Company Inc.) and in 2000 was appointed Chairman, President and CEO of A&P Canada. In late 2002 he moved to the U.S. as President and Chief Executive Officer of A&P US (New York Stock Exchange symbol "GAP") where he began the turnaround of North America's oldest retail food chain. Brian retired from A&P in July 2005. Brian has been recognized for his achievements throughout his career including "President of the Year" by the Jim Pattison Group for the outstanding financial performance of Overwaitea in 1993. Brian is an MBA graduate and has served on many voluntary boards.

About Skinvisible Pharmaceuticals, Inc.

Skinvisible Pharmaceuticals, a wholly owned subsidiary of Skinvisible Inc., is a research-and-development company whose primary business objective is to license its proprietary formulations with Invisicare to pharmaceutical and cosmeceutical companies as well as assisting companies in revitalizing or enhancing their existing skin care products. Skinvisible receives a combination of research and development fees, upfront license fees, and ongoing royalties for the life of the patent. http://www.skinvisible.com

About Invisicare(R)

Invisicare is a patented polymer delivery system developed to hold active ingredients topically on the skin for extended periods of time. A key benefit is that Invisicare is non-occlusive on the skin, allowing normal skin respiration and perspiration. The Company has developed a portfolio of topical products using Invisicare for the dermatology and cosmeceutical industries. http://www.invisicare.com

Forward-Looking Statements

This press release contains 'forward looking' statements within the meaning of Section 21A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and are subject to the safe harbors created thereby. Such statements involve certain risks and uncertainties associated with an emerging company. Actual results could differ materially from those projected in the forward looking statements as a result of risk factors discussed in Skinvisible, Inc. reports on file with the U.S. Securities and Exchange Commission (including, but not limited to, a report on Form 10Q for the quarter ending December 31, 2007).

Corporate Contact:

Terry Howlett, President/CEO

Skinvisible Pharmaceuticals, Inc

Phone: 702-433-7154

Email: info@skinvisible.com


'/>"/>
SOURCE Skinvisible, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Skinvisible Announces Licensing Agreement for Adapalene
2. Skinvisible Signs Marketing Agreement for India
3. Skinvisible Appoints Dr. George Korkos to Its Advisory Board
4. Skinvisible to Present at Merriman Curhan Ford & Co.s Investor Summit 2007
5. Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors
6. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
7. Crdentia Appoints Charlie Mayhone to Director of Operations for its National Travel Division and Charlotte, North Carolina Market
8. National Institutes of Health Appoints Timothy C. Birdsall, ND to CAM Advisory Council
9. CPF Appoints Mishka Michon Chief Executive Officer
10. QualityMetric Appoints Chief Innovation and Research Officer
11. Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... D.C. (PRWEB) , ... April 28, 2016 , ... The ... and Prevention (CDC) has established an ICD-10-CM code for sarcopenia, giving it recognition for ... the medical community effective October 1, 2016. , Sarcopenia is defined as a combination ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... insurance co-operative bankruptcy to receive their prescription medications through America’s fastest-growing pharmacy ... prescription medications from over 180 American pharmaceutical companies for $35 per month, ...
(Date:4/28/2016)... ... April 28, 2016 , ... ... offering, the Protocol Calendar Exchange , is officially open to all sponsors ... calendars available for sites to download into their clinical trial management system (CTMS), ...
(Date:4/28/2016)... ... 2016 , ... On Thursday, April 14 orthopaedic surgeon ... Institute in Vail, Colorado, attended the American Academy of Orthopaedic Surgeons (AAOS) ... musculoskeletal disorders that are affecting millions of Americans today. Dr. LaPrade and many ...
(Date:4/28/2016)... Valley, California (PRWEB) , ... ... ... Inc. (AGNITY) a leading global provider of intelligent business communication applications and ... and go-live of its Number Portability solution at Bestel’s Communications Network. ...
Breaking Medicine News(10 mins):
(Date:4/26/2016)... CLEVELAND , April 26, 2016 ... is forecast to expand 4.9 percent annually to ... and other healthcare facilities to decrease rates of ... infection prevention supplies, equipment, and services.  Although declining, ... is significantly above targeted levels set by the ...
(Date:4/26/2016)... Bayer AG has reported first-quarter ... and amortization. The earnings are the result of a ... Xarelto and Eylea, drugs Bayer is banking on to ... date was extended by four years this week to ... to reach a value of USD 1,147.1 billion ...
(Date:4/26/2016)... , April 26, 2016 ... Microbial identification Market Size, Share, Development, Growth ... Insights by Product (Consumables, Instruments and Software ... Genotypic Method), by Application (Diagnostic Application, Food ... Application) and by End User (Hospitals, Pharmaceutical ...
Breaking Medicine Technology: